Aging Clinical Trials
A listing of Aging medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 587 clinical trials
Athlete Brain Health and Aging Study
The Athlete Brain Health and Aging Study is currently conducting research on former D1 collegiate athletes and former NFL players above the age of 30. Participation in the study will assist with
- 114 views
- 19 Jan, 2023
- 1 location
- Online study
Building Community and Research Engagement among Sexual and Gender Minority Older Adults at Risk for Alzheimer’s Disease and Related Dementias
The RISE Registry - (Research Inclusion Supports Equity) is a national effort to address the needs of 18+ LGBTQIA+ who: Have memory concerns or a memory loss diagnosis such as Alzheimer's disease or related dementia (ADRD) Are helping care for someone with memory loss or a memory loss diagnosis Individuals …
- 32 views
- 24 Jan, 2023
- 1 location
- Online study
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to placebo in subjects with early Parkinson's Disease who are not receiving dopaminergic therapy. Part 2 is an optional long term extension study for …
- 75 views
- 26 Jan, 2023
- 75 locations
Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa (Baby-COMET)
This is a single group, treatment, Phase 3, open-label study to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in treatment-naïve male and female participants with IOPD. Study details include: Study duration: Screening - up to 4 weeks; Primary Analysis Period (PAP) - 52 weeks; Extended Treatment Period …
- 8 views
- 31 Jan, 2023
- 3 locations
Dupilumab in CRSsNP (Liberty CRSsNP ORION)
Primary Objective: Part A and B: To evaluate the efficacy of dupilumab as assessed by the reduction at Week 24 in sinus opacification on computerized tomography (CT) scan and sinus total symptom score (sTSS) compared to placebo Secondary Objectives: Part A To evaluate the efficacy of dupilumab as assessed by …
- 20 views
- 31 Jan, 2023
- 8 locations
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)
This is a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma. Study details include: The study duration (per participant) will be …
- 20 views
- 31 Jan, 2023
- 5 locations
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 (LEAP2MONO)
This is a parallel arm, Phase 3, double-blind, double-dummy, active-comparator, 2 arm study to evaluate the efficacy and safety of daily oral venglustat versus intravenous Cerezyme infusions every two weeks for improvement or stabilization of the neurological manifestations and maintenance of systemic disease stability in participants aged ≥12 and <18 …
- 9 views
- 31 Jan, 2023
- 1 location
Aging Research Characterizing Health Equity via Social determinants (ARCHES)
Black Americans have more occurrences of chronic diseases, a higher rate of death, and are at twice the risk of Alzheimer’s disease (AD) compared to White Americans. However, these differences aren’t tied to the individual communities. They are tied to the conditions of the environment surrounding them (e.g., stress, discrimination, …
- 4 views
- 23 Jan, 2023
- 1 location
COMMANDS - Myelodysplastic Syndromes (MDS) - ACE536-MDS-002 - Australia
The study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This is an interventional active-controlled, open-label, randomized Phase 3 study to compare the efficacy and safety of luspatercept (ACE-536) …
- 16800 views
- 22 Aug, 2022
- 7 locations
Sickle Cell Disease Research Study - Fulcrum Therapeutics
The purpose of this study is to determine the safety and clinical effects of SCD-101 when given to adults with sickle cell disease.
- 12956 views
- 31 Jan, 2023
- 5 locations